Skip to main navigation Skip to search Skip to main content

Phase I and pharmacologic study of weekly doxorubicin and 1 h infusional paclitaxel in patients with advanced breast cancer

  • V.R Nannan Panday
  • , W.W. ten Bokkel Huinink
  • , H. Rosing
  • , F.J. Koopman
  • , M.J.X. Hillebrand
  • , A.C. Dubbelman
  • , O. van Tellingen
  • , J.H.M. Schellens
  • , J.H. Beijnen
  • extern

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)665-673
Number of pages9
JournalAnti-Cancer Drugs
Volume9
Publication statusPublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medical technology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Public Health
  • Analytical chemistry
  • Drugmisbruik en verslaving

Cite this